Eilidh Bedford

As the Chief Technology Officer at Cytiva Bioprocess, a biotechnology group within Danaher Corporation, I lead the research and development of breakthrough materials innovations for life science applications. I have a proven track record of delivering high-impact products and technologies and leading great teams. My core competencies include R&D strategy, team leadership, product development, materials characterization, and invention of new technologies. I have a PHD in Natural Sciences from the University of Cambridge, with a focus on Materials Science. I am also an advisory board member of Harvard Materials Research, where I collaborate with leading researchers and academics in the field. My mission is to leverage my expertise and passion for materials science and biotechnology to create innovative solutions that improve health outcomes and drive environmental sustainability.